STUDY OF PREFERENCES IN MEN FACED WITH THE DIFFERENT TREATMENT OPTIONS FOR LOCALIZED PROSTRATE CANCER WITH A GOOD OR INTERMEDIATE PROGNOSIS
NCT ID: NCT02080793
Last Updated: 2019-05-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
652 participants
INTERVENTIONAL
2013-05-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. One specific questionnaire that has already been developed from social sciences interviews conducted in men who have been treated for localized prostrate cancer, with a good or intermediate prognosis. This questionnaire comprises 11 pairs of scenarios. Each scenario gathers in a random manner, the modalities of 7 possible characteristics of the management strategy for localized prostrate cancer, with a good or intermediate prognosis:
* the risk of death at 5 years (modalities: 5%, 15%),
* the risk of impotence (modalities: 0%, 25%, 50%, 75%),
* the presence of urinary leaks (modalities: no protection during the day, one protection pad per day, several protection pads per day),
* the duration and frequency of care provided (modalities: 2 days of care in your whole life, 7 days of care in your whole life, 5 half-days of care per week for 8 weeks, every 3 months for 2 years then every 6 months for life),
* ablation of the prostate (modalities: Yes, No),
* the existence of possible treatments in case of aggravation or recurrence (modalities: Yes, No),
* the nature of the technology used (modalities: innovative technology, standard technology).
The objective is to ask each participant of the study for each pair of scenarios, to choose from the two scenarios (binary-choice survey), the scenario he prefers.
2. The "Spielberger Inventory Trait" scale to evaluate stable characteristics in the propensity to anxiety in study participants.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Geriatric Determinants of General Repercussion of Radiotherapy for Patient Over 75 Years With Prostate Cancer
NCT02876237
Development of a Therapeutic Education Program for Patients With Metastatic Prostate Cancer Treated With New Generation Hormone Therapy
NCT04048252
Shared Decision Making in Low Risk Prostate Cancer
NCT01673581
Study of Geriatric Patients Aged 75 Years or Older Treated and Cured for Localized Prostate Cancer: Case-control Study
NCT01797692
Impact of a Printed Decision Aid on Patients' Intent to Undertake Prostate Cancer Screening
NCT02156869
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients phase pilote
Questionnaire
Patients phase réelle
Questionnaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged 50 to 70 years
* seen at a urology consultation
* able to understand written and spoken French
* who have provided written informed consent
Exclusion Criteria
* under guardianship or wards of court
* who have already been diagnosed withor treated for prostrate cancer
* with recently diagnosed cancer or on treatment for this cancer
50 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique St Marie
Chalon-sur-Saône, , France
CHU de DIJON
Dijon, , France
Hôpital TENON
Paris, , France
CHU de TOURS
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LEJEUNE-CORMIER INCA 2012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.